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Xenopus laevis oocytes were injected with mRNA extracted from growth factor-responsive CCL39, Chinese hamster lung fibroblasts. The expression 
of functional growth factor receptors on the oocytes was demonstrated by growth factor-induced 45Ca2’ efflux. To determine the isozyme(s) of 
phospholipase C (PLC) coupled to growth factor receptors, growth factor-induced 45Ca2+ efflux were measured following coinjection of mRNA 
from CCL39 cells with PLC antibodies. PLCql antibody did not lead to loss of 45CaZ’ et&x induced by thrombin but resulted in loss of that 
induced by platelet-delved growth factor (PDGF). In contrast, PLC-lil antibody did not block PDGF-indu~d “‘Ca*’ etllux but led to jnhibition 
of thrombin-induced ‘?a2’ effhtx. PLC-pl antibody did not affect Ca*’ eftlux by the treatment of either thrombin or PDGF. These results suggest 
that these growth factor receptors are coupled to specific effecters, i.e. thrombin receptor to PLC-Sl and PDGF receptor to PLC-yl. 
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1. INTRODUCTION 
Stimulation of a variety of cell surface receptors re- 
sults in the activation of inositol phospholipid-specific 
phospholipase C (PLC). Activated PLC hydrolyzes 
phosphatidylinositol 4,5-bisphosphate (PIP,) to gener- 
ate inositol-1,4,5 trisphosphate (IP,) and diacylglycerol 
(DG) [l]. IP, releases Ca2’ from intracellular stores, 
whereas DG activates protein kinase C (PKC) [2,3]. The 
PLC enzymes are subdivided on the basis of cDNA 
cloning and deduced amino acid sequence similarity 
into at least three well defined groups: PLC -8, -y, and 
-s [l]. 
Growth factors such as epidermal growth factor 
(EGF) and platelet derived growth factor (PDGF) stim- 
ulate cell growth via multiple signal transduction path- 
ways that include PLC-mediated hydrolysis of PIP,. 
EGF and PDGF lead to an increase in the phosphoryl- 
ation of PLC-y, but not PLC-/I or PLCd [4-61. This 
phosphorylation is mediated by the intrinsic tyrosine 
kinase activity of the receptors for EGF and PDGF [7]. 
CCL39, a line of Chinese hamster lung fibroblasts is a 
good model system for studing signal transducing 
mechanisms involved in growth factor activation of cell 
division. T~ombin is a potent mitogen for CCL39 cells 
and one of the post-receptor events stimulated by 
thrombin is phosphoinositide hydrolysis [8]. 
To identify which PLC isozyme is responsible for 
growth factor-induced PIP, hydrolysis, we have used 
Xenopus oocytes which could easily be injected mRNA 
from CCL39 cell or antibodies to PLC isozyme. In 
mRNA-injected oocytes PIP, hydrolysis resulting from 
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application of growth factor was indirectly demon- 
strated by mobilization of *%a’+ [8-lo]. Here we dem- 
onstrate that receptors for two growth factors, throm- 
bin and PDGF, in CCL39 cells are specifically linked 
to different PLC isozymes, PLC-81 and PLC-yl, re- 
spectively. 
2. MATERIALS AND METHODS 
2.1. Materials 
Thrombin, collagenase, soybean trypsin inhibitor were purchased 
from Sigma. PDGF (BB) was obtained from Promega. PLC$l, PLC- 
yl and PLCdl antibodies were generously provided by Dr. S.G. Rhee 
(NHLBI, NIH, USA). “‘Ca*’ was obtained from Amersham. [‘H]PIP, 
was purchased from New England Nuclear. 
2.2. Cells 
CCL39, Chinese hamster lung fibroblasts (ATCC) were maintained 
in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal 
bovine serum (FBS) contained in 75 cm* stock flasks under a humid- 
ified atmosphere of 95% air and 5% CO, at 37°C. 
2.3. RNA preparation 
Total RNA was extracted from CCL39 cells by the guanidium 
thiocyanate/cecium chloride gradient method of Chirgwin et al. [1 11, 
and mRNA was purified by oligo d(T)-cellulose afiinity chromatogra- 
phy. mRNA for microinjection was resuspended in filtered diethylpy- 
rocarbonate-treated H20 at a concentration of 2 mg/ml. 
2.4. Microinjection 
Ovarian fragments were surgically removed from adult female Xen- 
opus laevis (Xenopus I, Ann Arbor) and follicular cells surrounding 
the oocyte were removed by treatment for 2 h at room temperature 
with 2 mgiml collagenase and 0.4 mg/ml soybean trypsin inhibitor in 
modified Barths’ saline (MBS) (88.0 mM NaCI, 1.0 mM KCl, 2.4 mM 
NaHCO,, 15.0 mM HEPES PH. 7.6, 0.3 mM Ca(NO,),, 0.4 mM 
CaCl,, 0.82 mM MgSO,) containing penicillin (50 units/ml) and strep- 
tomycin (50 &ml). Dumont stage V and VI oocytes were microin- 
jetted with approximately 50 nl RNA solution. After injection, 
oocytes were stored at 20°C in MBS; this medium was changed aily. 
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2.5. Immrrnoprecrpitation and immunoblotting 
CCL39 cells or oocytes were homogenized in 1 ml of ice-cold lysis 
buffer (20 mM HEPES. pH 7.2, 1% Triton X-100, 10% glycerol, 50 
mM NaF. 1 mM phenylsulfonylfluoride, 10 &ml leupeptin, lO,&/ml 
aprotinin) by 10 strokes with a Kontes Pellet Pestle Mortar. After 
centrrfugation, the soluble extracts were treated with one of the mrx- 
ture of monoclonal antibodies to PLC isozymes for 4 h and then with 
10 of the heat-inactivated. precoated S. aweus cells [12]. The im- 
munoprecipitates were washed with a washing buffer (1.0% Triton 
X-100, 1 .O% deoxycholate, 0.1% SDS, 150.0 mM NaCI, and 50.0 mM 
Tris. pH 8.5). Immunoprecipitated proteins were released by the addi- 
tton of 20.0 ,~l Laemmli buffer and heating for 5 min at 95°C. SDS- 
polyacylamide gel by the method of Laemmli [13], and the separated 
proteins were then transferred to nitrocellulose for 2 h at 50 V. After 
blocking with 2% bovine serum albumin, the filters were probed with 
a mixture of monoclonal antibodies of each PLC isozyme. Immune 
complexes were detected with alkaline phosphatase-conjugated anti- 
body to mouse IgG and a phosphatase substrate system. 
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2.6. 4’C&+-efJux assq 
24 h after mRNA injection when the growth factor-responses a  well 
as the gross-appearances of the oocytes were best, oocytes were incu- 
bated for 2.5 h at 20°C in MBS containing 50 ,&ilml 45Ca2’. Follow- 
ing “Ca’+ loading oocytes were rinsed three times with MBS at room 
temperature and placed in individual perfusion chambers, each con- 
taining 0.5 ml of MBS plus soybean trypsin inhibitor (1 mg/ml). This 
medium was collected for determination of radioactivity at the indi- 
cated time. 
Fig. 1. Protein immunoblot showing the expression in CCL39 cells. 
Three isoforms of PLC were immunoprecipitated individually by 
using monoclonal antibodies pecific to PLC;Bl, PLC-yl and PLCdl. 
The immunoprecipitated proteins were separated by 7.5% SDS- 
PAGE, transferred to nitrocellulose membranes, immunoblotted with 
PLC-/Il. -yl and -61 antibodies, respectively. The protein bands were 
3. RESULTS visualized with alkaline phosphatase substrate system. 
3.1. Expression of PLC isozymes in CCL39 cells and 
mRNA-injected Xenopus oocytes 
We immunoprecipitated PLC isozymes from lysates 
of CCL39 cells and oocytes which had been injected 
with mRNA from CCL39 cell, and immunoblotted 
using PLC isozyme-specific antibodies. CCL39 cells ex- 
pressed at least three PLC isozymes, PLC-pl, PLC-71, 
and PLC-81, that exhibit apparent molecular masses of 
150, 145, and 85 kDa, respectively, on SDS-polyacyl- 
amide gels (Fig. 1). Xenopus oocytes have only PLC-~1 
as an intrinsic PLC enzyme, but expressed all three PLC 
isozymes, as in CCL39 cells, after injected with mRNA 
(Fig. 2). These results suggest hat Xenopus oocytes ex- 
pression system works well for studying growth factor- 
induced signaling mechanism in CCL39 cells. 
that the full repertoire of signaling machinery for 
growth factors was expressed in oocytes by mRNA in- 
jection. 
3.3. Effects of PLC isozyme antibodies on 45Cd+ efflux 
stimulated by growth factors 
To elucidate which isoform of PLC might be coupled 
3.2. Growth factor responses in mRNA-injected Xen- 
opus oocytes 
To evaluate whether the mRNA-injected oocytes are 
functionally intact we measured 45Ca2’ efllux resulting 
from application of thrombin or PDGF. Non-injected 
oocytes did not show any response to the treatment of 
thrombin or PDGF (Fig. 3a). This result suggested that 
the oocytes used in these experiments did not have en- 
dogenous thrombin or PDGF receptors, and/or the rel- 
evant signaling system. However, in oocytes which had 
been injected with mRNA from CCL39 cells, 45Ca” 
et&x was induced by treatment with either thrombin 
or PDGF (Fig. 3b). Taken together with the data from 
expression of the three PLC isozymes in oocytes injected 
with mRNA from CCL39 cells, these results establish 
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Fig. 2. Expression of PLC isozymes in Xenopus oocytes. Intact oocytes 
(1) or oocytes which have been injected with mRNA from CCL39 cells 
(2) were lysed. immunoprecipitated, and immunoblotted as described 
in Fig. 1. 
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Fig. 3. “Caz+ efkx stimulated by growth factors. %a’+ efflux was determined on single oocytes either non-injected (a) or microinjected with mRNA 
from CCL39 cells (b). Thrombin (1 U/ml) (@ or PDGF (200 @ml) (A) or vehicle (0) were added where indicated by arrows. The medium (100 
~1) was collected and fresh medium were replaced every 5 min. The results are expressed as means + S.E.M. 
to each growth factor receptor, we measured 4sCa2+ 
et&x in oocytes which had been coinjected with mRNA 
from CCL39 cells and antibodies to each specific PLC 
isozymes. In the case of oocytes coinjected with PLC-PI 
antibody, 45Ca2+ e&x induced by thrombin or PDGF 
was unaffected (Fig. 4a). In contrast, in oocytes which 
had been coinjected with mRNA from CCL39 cells and 
PLC-yl antibody 45Ca2+ elllux induced by PDGF was 
completely blocked, although thrombin was still effec- 
tive (Fig. 4b). On the other hand, in oocytes which had 
been coinjected with mRNA from CCL39 cells and 
PLC-61 antibody, PDGF induced 45Ca2+ efllux but 
thrombin had no effect (Fig. 4~). 
4. DISCUSSION 
In this study, CCL39 cells have been found to express 
at least three PLC isozymes, PLC-#?I, -yl, and -61. 
These PLC isozymes could be expressed by microin- 
jetting mRNA from CCL39 cells into oocytes, which 
have only endogenous PLC-yl. PLC-J?l expressed in 
injected oocytes was MW 100 kDa in addition to the 
0 5 10 15 20 25 30 0 5 10 15 20 25 30 0 s 10 15 20 2.5 30 
Time (min) Time (min) Time (tin) 
Fig. 4. Effects of PLC isozyme antibodies on 45Ca2’ ef’fiux stimulated by growth factors. 4sCaz+ efflux was determined on single oocytes coinjected 
mRNA from CCL39 cells with PLC,Sl antibody (a), PLC-11 antibody (b), or PLC-61 antibody (c). Thrombin (1 U/ml) @) or PDGF (200 ng/ml) 
(A) or vehicle (0) were added where indicated by arrows. The medium (100 ~1) was collected and fresh medium were replaced every 5 min. The 
results are expressed as means + S.E.M. 
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authentic, MW 150 kDa in CCL39 cells. PLC-/31 has 
been known to be highly susceptible to proteolysis and 
contain amino acid sequences which are specific sites for 
the 45Ca2’-dependent protease, calpain [14]. Binding of 
growth factors, such as PDGF, to their receptors, in- 
trinsic tyrosine kinase is activated and this phospho- 
rylates several target proteins including PLC-yl, which 
hydrolyzes PIP, [4-61. Although Xenopus oocytes have 
endogenous PLC-~1, PDGF could not induce 45Ca2+ 
efllux (Fig. 3a). This result suggests that oocytes used 
in this experiment did not have endogenous PDGF re- 
ceptors. The fact that thrombin also could not induce 
45Ca2+ eIlIux in oocytes agrees with a previous report 
that endogenous thrombin receptors are depleted in 
oocytes following long treatment (> 1.5 min) with col- 
lagenase [S]. However, mRNA-injected oocytes showed 
45Ca2+ efflux in response to application of either throm- 
bin or PDGF (Fig. 3b). The 45Ca2+ eflluxes in oocytes 
induced by these two growth factors had very similar 
patterns in response time and amplitude. 
Coinjection of PLC-/31 antibody into oocytes had no 
effect on the 45Ca” efIIux induced by the treatment of 
either thrombin or PDGF (Fig. 4a). This finding sug- 
gests that intracellular antibody injection itself has no 
effect on growth factor signaling. The results showing 
that PLC-yl antibody completely blocked PDGF-in- 
duced 4sCa2+ eMlux but PLC-/?l or PLCdl antibodies 
had no effect are consistent with the view that the 
PDGF receptor is coupled exclusively to PLC-)11 [6]. In 
contrast, the PLC-81 antibody completely blocked the 
thrombin-induced 45Ca2+ efflux (Fig. 4~). This result 
was confirmed by PLC assays; the PLCBl antibody 
completely inhibited thrombin-induced PIP2 hydrolysis 
to the basal level, whereas PLC-/I1 antibody or PLC-~1 
antibody only slightly inhibited thrombin-induced PIP, 
hydrolysis (data not shown). These results suggested 
that the blockage of thrombin-induced Ca” eftlux by 
the PLC61 antibody resulted from inhibition of the 
PLC-&-catalyzed hydrolysis of PIP,. In a previous 
study, a mutant of CCL39 cells, which had no detecta- 
ble PLC-81 was found to be defective in thrombin-in- 
duced mutagenesis [15]. However, a definitive conclu- 
sion could not be made because PLC-y from mutant 
extracts showed altered catalytic behavior in contrast to 
PLC-y from wild type extracts. 
In conclusion, we would consider the Xenopus 
oocytes expression system as ideal for studying growth 
factor-activated signalling pathways. Furthermore, an- 
tibodies to specific PLC isozymes could be used to selec- 
tively block the growth factor-induced signals so as to 
dissect the signalling pathways. 
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